Abstract

Background: The role of long non-coding RNAs has been extensively appreciated in the contexts of cancer. Interferon gamma-antisense RNA1 (IFNG-AS1) is an lncRNA located near to IFN-gamma-encoding (IFNG) gene and regulates expression of IFNG in Th1 cells. Methods: In the present study, we evaluated expression of IFNG and IFNG-AS1 in 108 breast samples including tumoral tissues and their adjacent non-cancerous tissues (ANCTs) using real-time PCR. IFNG-AS1 was significantly upregulated in tumoral tissues compared with ANCTs (expression ratio = 223, P= 0.03). Results: Although the expression of IFNG was higher in tumoral tissues compared with ANCTs (relative expression = 1.89), it did not reach the level of significance (P= 0.07). IFNG expression was significantly higher in HER2-negative tumoral tissues compared with HER2-positive ones (P = 0.01) and in grade 1 samples compared with grade 2 ones (P= 0.03). No other significant difference was found in expressions of genes between other groups. Conclusion: Significant strong correlations were detected between expression of IFNG and IFNG-AS1 in both tumoral tissues and ANCTs. The present study provides evidences for participation of IFNG and IFNG-AS1 in the pathogenesis of breast cancer and warrants future studies to elaborate the underlying mechanism.